FAS and chronic myelogenous leukemia, BCR-ABL1 positive: C16-ceramide has also been shown to increase the sensitivity of Jurkat T cells and hepatocytes [25], and human chronic myelogenous leukemia (CML) [26] to Fas-mediated apoptosis.